Brainstorm Cell Therapeutics (BCLI) Earnings Date & Reports

Industry: @Computer Peripherals

Get AI intraday signals

A.I. Advisor

published Earnings

BCLI is expected to report earnings to fall 93.89% to -10 cents per share on April 01

Brainstorm Cell Therapeutics BCLI Stock Earnings Reports

Q4'23

Est.

$-0.11

Q3'24

Missed

by $1.76

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.02

Q3'23

Missed

by $0.14

The last earnings report on November 14 showed earnings per share of -179 cents, missing the estimate of -3 cents. With 494.90K shares outstanding, the current market capitalization sits at 10.21M.

View a ticker or compare two or three

Compare

BCLI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BCLI
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biotechnology company, which develops innovative adult stem cell therapeutic products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Computer Peripherals

Address

1325 Avenue of Americas

Phone

+1 201 488-0460

Employees

Web

https://www.brainstorm-cell.com